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Abstract 
Treatment of relaxed skinned rabbit psoas muscle fibers with 0.1 mM N-phenylmaleimide (NPM) for 1 h locks all of the crossbridges 
in a weakly-binding state resembling that of the myosin'ATP crossbridge. Under these conditions, NPM reacts mainly with myosin heavy 
chain (Barnett et al. (1992) Biophys. J. 61,358-367). Here the specific sites for that reaction are explored. Small bundles of rabbit psoas 
muscle fibers were treated with Triton X-100 to make the fiber sarcolemmas permeable. The bundles were treated with 0.1 mM 
[14C]NPM for 1 h, and homogenized for SDS-PAGE. 43 + 2.2% of the muscle fiber protein ran in the myosin heavy chain band, the same 
as for untreated fibers. An alkylating stoichiometry of 2.2 + 0.33 moles NPM per mole myosin heavy chain was determined. Exhaustive 
trypsin digestion followed by two-dimensional thin-layer chromatography and reverse-phase HPLC revealed two major sites on myosin 
heavy chain for NPM binding. The sites contained about he same amount of linked NPM, suggesting that the reaction stoichiometry of
each site under the conditions tudied is approx. I tool NPM/mol myosin heavy chain. Comparison of the labeled tryptic peptides with 
NPM-reacted synthetic SHI and SH2 tryptic peptides and analysis of the treated fiber bundles' ATPase activity suggested that the sites 
for NPM reaction on myosin heavy chain when it locks crossbridges in a weakly-binding state are Cys-697 (SH2) and Cys-707 (SH1). 
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I. Introduction 
Vertebrate skeletal muscle is composed of several pro- 
teins that work together as a functional unit, myosin being 
one of the major proteins. The myosin molecule consists of 
a helical coiled region from which two globular 'heads' 
emerge. Each myosin molecule is composed of two heavy 
chains and two pairs of light chains [1]. Myosin heavy 
Abbreviations: NPM, N-phenylmaleimide; pPDM, para-phenylen- 
edimaleimide; SH1, myosin's most reactive sulfhydryl, Cys-707; SH2, 
myosin's econd most reactive sulfhydryl, Cys-697; MHC, myosin heavy 
chain; SDS, sodium dodecylsulfate; PA, polyacrylamide; SDS-PAGE, 
sodium dodecylsulfate polyacrylamide gel electrophoresis; DTr, dithio- 
threitol. 
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chain has a molecular mass of ~ 220 kDa and represents 
~ 43% of muscle fiber protein [2]. 
Myosin heavy chain contains 42 cysteine residues. The 
two most reactive of these, SHI and SH2, are located near 
the carboxy-terminal end in the head region. In solution, 
these sulfhydryls can be modified by alkylating agents 
such as para-phenylenedimaleimide (pPDM) or N-phenyl- 
maleimide (NPM) [3,4]. This modification locks the myosin 
in a weakly-binding state resembling the normal 
myosin "ATP state. 
The effect of pPDM and NPM in muscle fibers is 
similar to their effect upon myosin in solution. Treatment 
of muscle fibers with these compounds locks the cross- 
bridges in a state that resembles that of the normal myosin 
• ATP crossbridge of relaxed fibers• Although analogy 
with the solution studies makes it likely that the effect of 
pPDM and NPM on muscle fibers is due to binding to the 
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SH1 and SH2 sulfhydryls of myosin heavy chain, no direct 
evidence supporting this is available. Previously we showed 
[5] that the main site of pPDM and NPM-reactivity with 
muscle fiber treatment is myosin heavy chain. Here, we 
show that under conditions identical to those used in our 
previous tudy, conditions where 100% of a treated fiber's 
crossbridges are locked in the weakly-binding state, NPM 
alkylates with a stoichiometry of approximately I mol/mol 
to SHI and 1 mol/mol to SH2. 
2.3. Homogenization of.fiber bundles 
Treated bundles were removed from the staples and 
homogenized in 0.2 ml homogenization buffer (2 mM 
EDTA in 20 mM Tris (pH 8)), using a micro tissue grinder 
(Wheaton, Millville, NJ) in an ice-water bath. After four or 
five specimens had been ground in the 0.2 ml, enough 
homogenization buffer was added to bring the protein 
concentration to 2 mg/ml  as determined by the Lowry 
assay [9]. 
2. Methods 2.4. Quantitatite SDS-PAGE 
2.1. Treatment of fiber bundles to make the sarcolemmas 
permeable 
Before the fibers within a muscle fiber bundle can be 
reacted with pPDM or NPM, the plasma membranes sur- 
rounding the individual muscle fibers must be made per- 
meable. The protocol that makes the sarcolemmas of single 
muscle fibers permeable [6] was not totally adequate for 
fiber bundles [7]. A more rigorous procedure was used, 
based upon the method of Magid and Reedy [8]. 
Strips of rabbit psoas muscle tissue (80 × (4-6 ram)) 
were removed from 2-3 kg New Zealand rabbits and 
incubated in skinning solution [6] for 30 rain. Muscle 
bundles (12 X (0.2-0.5 ram)) were dissected from the 
strips and fixed between the arms of stainless teel staples 
using cyanoacrylate glue. Each small fiber bundle was 
placed in a 1.5 ml Eppendorf tube and incubated, with 
agitation, ~ 18 h at 4°C in skinning solution containing 
0.5% (vol/vol)Triton X-100. 
2.2. Treatment of fiber bundles with [14 C]NPM 
After the sarcolemmas were made permeable, the skin- 
ning solution was removed and the fiber bundles were 
incubated (2 x ) for 15 rain in Triton-free, dithiothreitol- 
free relaxing solution. [14C]NPM (10 mM in dimethyl- 
formamide, stored for less than 30 days) was added at the 
desired concentration directly to the dithiothreitol-free r - 
laxing solution. The contents of the relaxing solution, 
shown in Table 1, and the treatment duration for labeling 
the fibers, are identical to those used in our previous tudy 
[5]. 
Table I 
Millimolar composition f relaxing solution 
KCI 125 
EGTA 4 
MgCI z I 
MgATP 4 
Imidazole I 0 
pH 7.0 + 0.1 5°C. 
Fiber homogenates (0.5-1.5 /~g) and myosin heavy 
chain (0.25 to 0.75 /xg, kindly provided by Dr. James 
Sellers) were mixed 1:1 with electrophoresis sample buffer, 
heated in boiling water for 2 min, and electrophoresed on a 
2-12% gradient SDS-PA gel [10] at 250 V for ~ 2.5 h. 
Gels were stained with Coomassie blue (0.063% brilliant 
blue R-250 in Destain I (methanol/acetic acid/water, 
5:1:4)). Gels were placed in Destain I for 1 h and Destain 
II (methanol/acetic a id/water, 6:3:31) for 3.5 to 5 h. For 
trypsin digestion, gels were stained for only 10 min and 
placed in Destain I (15 min) and Destain II (60 min). 
2.5. Determination of the amount of 14C-label inked to the 
myosin heacy chain in SDS-PA gels 
Stoichiometry of the covalent reaction of [14C]NPM 
with myosin heavy chain was determined from the amount 
of radioactivity migrating with the myosin heavy chain 
band using the procedure of Mahin and Lofberg [11]. 
Slices (8 X 10 X 1.5 mm) of gels containing the myosin 
heavy chain band were oxidized (0.2 ml 60% perchloric 
acid) in a 7 ml liquid scintillation vial. After addition of 
30% hydrogen peroxide (0.4 ml) the mixture was incu- 
bated at 75-80°C for 60 min with gentle agitation. Occa- 
sionally, an additional 30 min of incubation was necessary 
to completely dissolve the gel slice. After cooling to room 
temperature, 6.25 ml of aqueous scintillation fluor 
(Ready-Safe, Beckman Instruments, Fullerton, CA) was 
added, equilibrated for more than 3 h, and counted for 10 
rain on a LS3801 liquid scintillation counter (Beckman 
Instruments, Fullerton, CA). Incubation for more than 3 h 
is required to allow decay of the substantial chemilumines- 
cence generated by perchioric acid and peroxide. 3 h 
incubation is sufficient, since subtraction of a non-radioac- 
tive control corrects for the remaining chemiluminescence. 
2.6. Specific activity of [14 CINPM 
NPM was labeled at the C-2 and C-3 positions of the 
maleimide ring (Amersham Corporation) as shown in Fig. 
1 at a nominal specific activity of 27.8 × 10 ~ dpm/mol. 
The measured specific activity of the labeled NPM was 
(21.2 + 1.4) X 1012 cpm/mol.  
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Fig. 1. Chemical structure of N-phenylmaleimide (NPM), showing the 
position of 14C labeling. For comparison, the structure ofpara-phenylen- 
edimaleimide (pPDM), the more commonly studied bifunctional kylat- 
ing reagent, also is shown. It is a carbon on either side of the double bond 
in the maleimide ring that links to the sulfur in cysteine inthe alkylation 
reaction. 
2.7. Tryptic digestion of the myosin from muscle bundle 
specimens 
Homogenized muscle protein (20 /xg per well) was 
electrophoresed and lightly stained. Strips of four myosin 
heavy chain bands were washed (2 x ,  25% isopropyl 
alcohol, 15 min, and 2 X, 10% methanol, 15 min). The 
4-band strips were divided in two; each 2-band strip was 
minced and air-dried overnight in an uncapped 14-ml test 
tube. 960 /xl of 50 mM NH4HCO 3 and 40 /~1 of 0.05 
mg/ml  TPCK-treated trypsin (Sigma, St. Louis, MO, T- 
8642) were added to the test tubes, which were capped and 
incubated (with agitation) at 37°C for 16-24 h. The liquid 
phase was pipetted to a 12-ml syringe, forced through a 
0.45 /xm filter (Millex-HA, Millipore), and lyophilized in 
a Speed-Vac Concentrator (Savant, Farmingdale, NY). The 
samples were re-suspended in 0.2 ml distilled water and 
lyophilized, two more times. 
2.8. Two-dimensional thin-layer chromatography oftryptic 
digests 
For the first dimension, horizontal electrophoresis, 
lyophilized tryptic digests were dissolved in 10 /zl of 
electrophoresis buffer (acetic acid/formic acid/water, 
3:1:16), applied to a 20 cm X 20 cm silica coated plate, 
and run at 1000 V for ~ 65 min at 4°C. For the second 
dimension of ascending chromatography, the dried plate 
was run for 5-6  h in 1-butanol/pyridine/acetic acid/water 
(13:10:2:8) [12,13]. Dried plates were scanned for 14C for 
17 h on a /3-scanner (AMBIS Radioanalytic Imaging 
Systems, San Diego, CA). 
2.9. Reverse phase HPLC of tryptic peptides 
The trypsin-digested lyophilized myosin heavy chain 
was dissolved in 330 /xl of solvent made up of 93% 
solvent A (0.1% trifluoroacetic acid in HPLC-grade dis- 
tilled water) and 7% solvent B (0.1% trifluoroacetic acid, 
80% acetonitrile). A small amount of the lyophilized mate- 
rial, containing less than 3% of theJaC-label, was insolu- 
ble. After centrifugation, 30 /xl of clear supernatant were 
removed for 14C-counting and 250 /zl were injected onto 
an HPLC column (0.46 X 25 cm Vydac reverse phase Cl8 
column 218RT54) attached to an HP1090 HPLC 
(Hewlett-Packard, Paio Alto, CA). Elution and separation 
of the peptides was accomplished with a gradient between 
solvents A and B. A gradient from 7% solvent B to 100% 
solvent B was completed in 55 min at 0.5 ml/min. The 
presence of peptides in the column eluate was monitored 
by absorbance at 214 nm. 50 /xl were removed from 120 
250-/zl fractions collected between 0 and 60 min and 
analyzed for radioactivity. 
2.10. Synthetic peptides 
The SHl-containing and SH2-containing tryptic pep- 
tides were synthesized (Peninsula Laboratories, Belmont, 
CA) using the known amino acid sequence of rabbit 
skeletal myosin heavy chain and the substrate specificity 
of trypsin [14,15]. Since the sequence of rabbit skeletal 
myosin in the SH1 and SH2 containing region of myosin is 
RCNGVLEGIRICR and since trypsin splits peptides at 
arginine and lysine, the tryptic peptides that contain SH1 
and SH2 are ICR and CNGVLEGIR, respectively [ 14,15]. 
The purity and identity of the peptides was checked by 
HPLC, thin-layer chromatography, amino acid analysis, 
and N-terminal sequencing. 
2.11. Stiffness and force measurements 
The stiffness of the treated muscle fibers in rigor solu- 
tion (136 mM KC1, 4 mM EGTA, 4 mM MgC12, 10 mM 
imidazole (pH 7.0)) was measured by stretching the mus- 
cle fibers 2 nm/half-sarcomere and measuring the change 
in force. The stretch was applied using a loudspeaker voice 
coil and the force was measured with a modified Sensonor 
(Horten, Norway) force gauge. Directions for mounting the 
fibers, and descriptions of the voice coil stretcher and force 
transducer, are given in Schoenberg and Eisenberg, 1985. 
Isometric force was measured in a solution containing 130 
mM potassium propionate, 2 mM MgC12, 5 mM MgATP, 
1 mM EGTA, 1.5 mM CaCI 2, and 10 mM Mops (pH 7.0). 
2.12. High-salt ATPase actiuity 
Myofibrils were made by grinding psoas fiber bundles 
with a Tekmar Tissuemizer in 10 mM Mops (pH 7.5). The 
protein concentration was determined by Biuret assay and 
incubation tubes were prepared by dilution of the myofib- 
rils into either EDTA-ATPase buffer (5 mM EDTA, 0.6 M 
KCI, 50 mM Mops (pH 7.5)) or Ca-ATPase buffer (10 
mM CaC12, 0.6 M KCI, 50 mM Mops (pH 7.5)). The 
reaction was initiated (25°C) by addition of ATP and 
activity was determined by measuring the production of 
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inorganic phosphate [16]. Myofibril protein concentrations 
were chosen to maintain a constant rate of phosphate 
liberation for at least 5 min. 
3. Results 
Both untreated and NPM-treated fiber bundles were run 
on SDS-PAGE with known concentrations of pure myosin 
heavy chain as standards (Fig. 2). From densitometric 
scans of the gels, the integrated area under the myosin 
heavy chain band of untreated fibers, NPM-treated fibers 
and pure myosin heavy chain was found to be linear with 
amount of protein loaded (data not shown). The ratio of 
the slopes of these lines showed that 49-+-2.7% of un- 
treated fiber protein (n = 12) ran in the myosin heavy 
chain band, in agreement with previous work (cf. Yates 
and Greaser, 1983). The NPM-treated fiber bundles howed 
43 + 2% of treated fiber protein (n = 8) in the myosin 
heavy chain band. This amount of myosin heavy chain is 
not significantly different from that of the untreated con- 
trol fibers (Student's t-test, P> 0.05), suggesting that, 
unlike the case for pPDM treatment which crosslinks 
myosin heavy chain [4], NPM treatment does not change 
the concentration of protein running in the myosin heavy 
chain band [5], 
Before determining labeling stoichiometry, two controls 
were performed. Non-radioactive gel slices were added to 
three concentrations of [ ~4 C]myosin (Dupont-NEN, Boston, 
MA) having 26 500, 53 000 and 79 500 cpm. The gel slices 
were dissolved and counted for radioactivity. In four ex- 
periments, an average of 89% of the counts were recov- 
ered. This was used as the counting efficiency. In a second 
control, 106000 cpm of the ~4C-labeled myosin were run 
on an SDS-PA gel; 97 190 cpm were recovered. After 
accounting for counting efficiency, it is seen that virtually 
all of the counts loaded onto an SDS-PA gel are recovered 
in the gel dissolving and counting procedures. 
Thirteen fiber bundles had their sarcolemmas made 
permeable and were incubated for 1 h with 0.1 mM 
[t4C]NPM. After 1 h, the reaction was terminated with 
DTT [5]. The fiber bundles were homogenized, elec- 
trophoresed, stained with Coomassie, and the radioactivity 
in the myosin heavy chain band was determined. There 
were 91.9 + 11.1 (n = 13) cpm in the myosin heavy chain 
band per /zg of fiber protein loaded. From these data, the 
stoichiometry of NPM alkylation of the myosin heavy 
chain was 2.2 _+ 0.33 mol/mol, suggesting that two sites 
are reacting with NPM. 
To determine whether NPM was labeling two sites 
stoichiometrically (1:1), as opposed to more than two sites 
sub-stoichiometrically, two methods (two-dimensional 
thin-layer chromatography and reverse-phase HPLC) were 
used to quantitate the number of specific reaction sites for 
NPM on the myosin heavy chain. 
Treated fiber bundles were homogenized and elec- 
trophoresed. The heavy chain was isolated, digested with 
trypsin, and lyophilized. For the two-dimensional chro- 
myosin --> 
actin ---> 
Control NPM 
Fiber MHC Fiber MHC 
i i f 'L~ L~ i [ i il~. } l .~ i  
0 ~ v- 0 0 0 v- v- 0 d 0 d 
----> 
Fig. 2. SDS-PAGE of muscle fiber bundles along side myosin heavy chain standard (MHC). (a) 0.5-1.5 /xg of control, untreated fiber bundles run next to 
0.25-0.75 /xg of myosin heavy chain. Exp 043091-1. (b) 0.5-1.5 /.tg of NPM-treated fiber bundles run next to 0.25-0.75 /xg myosin heavy chain. Exp. 
022191. 
A. Ehrlich et al. / Biochimica et Biophysica Acta 1232 (1995) 13-20 17 
matography, material from ~ 1 mg of muscle fiber protein 
was applied to a silica-coated TLC plate. As shown in Fig. 
3, radiolabeled trypsin-digested protein loaded at the origin 
separates into two main radioactive spots (B and C). A 
possible lightly labeled third spot (D) also is noted. Very 
little radioactivity appears to remain at the origin. The 
results are compatible with alkylation mainly at two sites. 
Reverse-phase HPLC (Fig. 4) similarly suggests that major 
labeling due to [14C]NPM occurs at just two sites on 
myosin heavy chain. Due to counting noise, the existence 
of additional, lightly labeled sites cannot be ruled out. 
We performed three types of experiment to identify the 
sites reacted. The most straightforward type of experiment, 
direct N-terminal sequencing of the eluant under the ra- 
dioactive peaks, repeatedly was unsuccessful. This proba- 
bly was due to the small amount of available starting 
material, the high molecular weight of myosin heavy chain, 
and the large number of tryptic peptides generated. The 
B 
A 
Fig. 3. fl-scan of a thin-layer silica plate after two-dimensional thin-layer 
chromatography of [t4C]NPM-labeled myosin heavy chain tryptic digest. 
Electrophoresis n the horizontal direction was followed by chromatog- 
raphy in the vertical direction. (B) and (C) show two radioactive spots, 
(D), a possible third spot. The origin (A) shows little radioactivity (see 
text). Exp. 120391. 
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Fig. 4. Reverse-phase HPLC chromatogram of ]4C-NPM-labeled, 
trypsin-digested myosin heavy chain. (A) Absorbance measured at 214 
nm. (B) Radioactivity of aliquots collected from RP-HPLC of tryptic 
digest. The net cpm from the aliquot fractions are plotted versus retention 
time, where retention time, with two aliquots per minute, is simply twice 
the aliquot tube number. The dashed curve shows the elution gradient 
which was: 0-35 min, 7-30%B; 50 min, 60%B; 55-65 min, 100%B. 
The vertical arrows show the retention times of synthesized SHI and SH2 
tryptic peptides reacted with NPM and eluted from the column using the 
same gradient. Exp. 111792. 
two other types of experiment, however, provided strong 
suggestive vidence that the sites reacted by NPM are 
Cys-707 and Cys-697, SH1 and SH2. 
As seen in Fig. 4A, tryptic digestion of myosin heavy 
chain generates many peptides. As seen in Fig. 4B, re- 
verse-phase HPLC elution typically separates the tryptic 
peptides into two main peaks of radioactivity, one having a 
retention time of 32 min and the other, 48.5 min. Since 
SH1 and SH2 are myosin's most reactive sulfhydryls, and 
those most likely to be reacting with NPM, and since the 
amino acid sequence of rabbit myosin heavy chain and the 
specificity of trypsin are known [14,15], we synthesized 
the tryptic peptides of myosin heavy chain that contain 
SH 1 and SH2. These synthetic peptides were reacted with 
N-phenylmaleimide and subjected to our standard reverse- 
phase HPLC gradient elution. NPM-treated SH1 peptide 
showed a retention time of 32.2 _ 0.09 min (n = 3) and 
NPM-reacted SH2 peptide showed a retention time of 
48.4_ 0.07 min (n = 3). These 2 are identical with the 
2 It was necessary, of course, to compare the retention times of the 
NPM-reacted fiber peptides with those of NPM-reacted synthetic pep- 
tides. The unreacted synthetic SHI and SH2 tryptic peptides howed very 
different retention times, 14.7 min (n=2)  and 35.6+0.1 min (n=4) ,  
respectively. 
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retention times of the radioactive peaks from trypsin-di- 
gested myosin heavy chain of treated fibers, strongly sug- 
gesting that under conditions where 100% of the cross- 
bridges are locked in a weakly-binding state, NPM reacts 
at Cys-697 (SH2) and Cys-707 (SHI)  on the myosin heavy 
chain. 
Another experiment suggesting that NPM reacts with 
SH1 and SH2 is based upon the observation that alkylation 
of these two cysteine residues in purified myosin affects 
the high salt ATPase in the presence and absence of 
divalent cations; modification of only SH1 results in a loss 
of EDTA-ATPase activity and a stimulation of the Ca 2+- 
ATPase activity, while modification of both SH1 and SH2 
results in an inhibition of ATPase activity under both 
conditions [17,18]. Fibers were incubated with NPM for 
time periods varying from 0 to 60 min. Myofibrils were 
made from the fiber samples and the EDTA- and Ca 2÷- 
ATPase of the myofibrils was measured in the presence of 
0.6 M KCI. As shown in Fig. 5, the fiber's EDTA-ATPase 
shows a steady decline to zero activity during 60 min of 
treatment. The Ca2+-ATPase (Fig. 6) shows a transient 
early increase and then a steady decline towards zero. The 
ATPase profiles that result from progressive NPM labeling 
of myosin in muscle fibers are indicative of modification 
of SHI followed closely by modification of SH2 [17,18]. 
A causal relationship between the ATPase results and the 
mechanical properties of NPM-treated fibers is further 
suggested by the observation shown in Figs. 5 and 6 that 
the elimination of the myosin ATPase activities occurs on 
the same time-scale as the loss of fiber isometric tension 
and rigor stiffness. 
We additionally made use of the EDTA- and Ca 2÷- 
ATPase measurements to verify the efficacy of our proce- 
dure for making the sarcolemmas throughout he fiber 
bundle permeable. The experiment of Fig. 5 was done on a 
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Fig. 6. Calcium activated force ([]) and Ca 2 +-ATPase (C)) as a function 
of treatment time in 100 /.LM NPM-containing relaxing solution. Both 
values normalized by corresponding values measured before treatment, 
1.9 kg/cm 2 for force and 0.09 /zmol Pi/mg myosin per min for 
Ca2-ATPase. Points and error bars show mean + S.E. (n = 5). 
fiber bundle whose diameter was comparable to those used 
in the other experiments. We also measured the EDTA- 
ATPase of treated fiber bundles having exceptionally arge 
diameter (0.76 mm). The fact that with our standard l-h 
NPM treatment the EDTA-ATPase was reduced more than 
200-fold from 1.04 to < 0.005 /zmol P Jmg per min pro- 
vides evidence that even fiber bundles considerably larger 
than those routinely used here have virtually all their 
sarcolemmas made permeable by the skinning procedure. 
The Ca2+-ATPase profile in the large bundles was similar 
to that observed for smaller ones, an activation of the 
ATPase for short incubations, followed by inactivation at 
the 1 h end-point (data not shown). 
4. Discussion 
2.00 
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Fig. 5. Stiffness in rigor solution (r-l) and EDTA-ATPase (©) as a 
function of treatment time in 100 /zM NPM-containing relaxing solution. 
Both values normalized by corresponding values measured before treat- 
ment, 8.2 dyn/nm for stiffness and 1.05 /xmol Pi/mg myosin per min 
for EDTA-ATPase. Points and error bars show mean_+ S.E. (n = 5). 
The coordinated movements of skeletal muscle can be 
attributed to the integrated action of several proteins, with 
actin and myosin having dominant roles. Modification of 
these proteins can be a useful tool for furthering our 
understanding of their function. Previously, Barnett et al. 
(1992) examined the effect of treating muscle fibers with 
the alkylating agents pPDM and NPM. Treatment with 
either of these agents produces muscles where the cross- 
bridges appear locked in a myosin ATP-like state charac- 
terized by weak binding to actin with very rapid detach- 
ment rate constants. 
pPDM and NPM link to a number of muscle fiber 
proteins [5] and have major effects on the interaction of the 
myosin crossbridges with actin. Since the effects seen are 
analogous to those when pPDM covalently links to the 
SHI and SH2 sulfhydryls of myosin in solution, it is likely 
that the physiological effects of these compounds in skele- 
tal muscle fibers is also due to their reaction with SH1 and 
SH2 on myosin. The current data strongly support this 
hypothesis. 
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In order to link NPM and pPDM to muscle fiber 
proteins, the sarcolemmal membrane surrounding the mus- 
cle fiber first must be made permeable. Previously we 
showed that the relatively mild 'skinning' procedure of 
Schoenberg and Eisenberg, 1985 [19], which works quite 
well for single fibers [6], was inadequate for 1-2 mm 
diameter muscle bundles [7]. In the present work we 
showed, using NPM's ability to inhibit the fiber EDTA- 
ATPase, that the 'skinning' procedure of Magid and Reedy 
(1980) works extremely well to make sarcolemmas perme- 
able, even in fiber bundles as large as 0.75 mm. 
After treating the permeable muscle fiber bundles with 
[14C]NPM, the stoichiometry of NPM alkylation of myosin 
was determined. The myosin heavy chain was separated 
from the rest of the muscle proteins using SDS-PAGE and 
the amount of J4C-label associated with myosin heavy 
chain was determined. This yielded a binding stoichiom- 
etry for NPM of 2.2 + 0.33 mol/mol under conditions that 
lock 100% of the crossbridges in a weakly-binding state, 
raising the possibility that NPM is producing its effect in 
muscle fibers by reacting with two sites on myosin. 
To further explore this, we examined where on myosin 
heavy chain [laC]NPM appeared to link. We did this by 
using two-dimensional thin-layer chromatography and 
HPLC to resolve tryptic digests of the myosin heavy chain 
from [J4C]NPM-treated fiber bundles. Both techniques 
suggested that the NPM label could be found mainly at 
two sites on myosin heavy chain. Co-elution on HPLC of 
the 14C-labeled tryptic peptides with NPM-treated syn- 
thetic SHI and SH2 peptides and inhibition of the muscle 
fiber's EDTA- and Ca2÷-ATPase activities with NPM 
treatment suggested that the reaction sites for NPM on 
myosin heavy chain are Cys-697 (SH2) and Cys-707 (SH1). 
A number of factors influence the susceptibility of 
myosin's sulfhydryls to alkylation. Although our results 
for NPM could not have been predicted a pr io r i ,  they are 
not surprising in light of previously published work. In 
general, the pattern of labeling depends upon the specific 
alkylating agent. Comparing just maleimide-based labels 
and iodoacetamide-derived labels, the latter are much more 
likely to label specifically at SH1 [20,18]. Another factor 
influencing the labeling pattern is nucleotide. The absence 
of nucleotide tends to inhibit reactivity of both SH1 and 
SH2 [21,4], PPi favors labeling at SHI [22], and ADP and 
ATP enhance the reactivity of SH2 [23-25]. 
SH1 and SH2 are located in what is likely a critical 
region of the myosin crossbridge head, near the base of the 
nucleotide binding pocket and also the cleft involved in 
actin binding [26]. In solution, pPDM treatment of myosin 
in the presence of ADP, leads to crosslinking of SH1 and 
SH2 with inhibition of the actomyosin ATPase and locking 
of myosin in a weakly-binding form [3,27]. Wells et al. 
[28], using different length crosslinkers, concluded that it 
was the reaction of SH1 and SH2, and not the crosslinking 
per se that was responsible for pPDM's action. The present 
results strongly support his conclusion. 
Our finding that linking NPM to SHI and SH2 induces 
a weakly-binding myosin state similar to that induced by 
pPDM opens up the possibility for exploring further the 
relative contributions of the SHI and SH2 modifications. 
Unlike the case for pPDM, with NPM it should be possible 
to alkylate SHI or SH2 singly, rather than concurrently as 
in the present work. While it already has been shown in 
solution that linking phenylmaleimide solely to SHI in- 
hibits actomyosin ATPase, it was observed also that, un- 
like the case for pPDM, this modification increases 
myosin's affinity for actin in the presence of ATP [22,29]. 
The mechanism by which linking phenylmaleimide 
groups to SH1 and SH2 locks crossbridges in a weakly- 
binding configuration is, as yet, unknown. This modifica- 
tion could be inhibiting a conformational change necessary 
for conversion to the strongly-binding configuration, or, 
alternatively, it could be interfering with communication 
between the ATP-binding and actin-binding sites, occu- 
pancy of the former normally determining affinity of the 
latter. 
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